Matthew Jenusaitis
As chief of staff for UC San Diego Health, Matthew Jenusaitis leads key initiatives in support of operational and strategic priorities to advance the organization's mission and vision. He serves as an executive liaison with the chief executive officer to provide management oversight and coordination of programs, initiatives and special projects, as well as deal with challenging situations and resolve problems. Additionally, Mr. Jenusaitis leads the enterprise-wide Project Management Office (PMO) to enhance performance management by improving operational efficiencies and reducing costs across UC San Diego Health.
Mr. Jenusaitis brings to this position more than 25 years of medical device industry, start-up and institutional investment experience focused on organizational growth, commercialization and operations. As a global life science executive, he has extensive expertise in the following clinical areas: cardiovascular, neurovascular, peripheral vascular and gastrointestinal interventional, as well as experience in both domestic and international management, sales and marketing, new product development, and non-profit fund raising, operations and management.
Before joining UC San Diego Health, Mr. Jenusaitis served as the president and chief executive officer of OCTANe, an Orange County, California non-profit organization focused on sparking innovation, starting new medical and high-tech companies, and creating jobs. OCTANe's accelerator program LaunchPad helped early-stage companies raise more than $700 million in capital and created more than 3,500 jobs in the region.
Before OCTANe, Mr. Jenusaitis worked with ConcepTx, identifying unmet clinical opportunities and developing new technologies and companies. He also served as the president of ev3 Neurovasuclar, leading their growing division (formerly MicroTherapeutics Inc.) through a combination of organizational development activities by launching and developing markets for a number of new products.
Mr. Jenusaitis spent 15 years at Boston Scientific Corp., most recently in the position of president of the $600 million Peripheral Interventions Division (formerly Medi-Tech) leading the acquisition and integration of Cryovascular Systems, Inc. and EndoTex, Inc. Before that, he held executive marketing and management positions in the Microvasive Endoscopy, International and Scimed Life Sciences divisions. During his career, Mr. Jenusaitis also spent eight years at Baxter Healthcare in both marketing and engineering management positions.
Mr. Jenusaitis holds a master of business administration degree from the University of California, Irvine, a master of science degree in biochemical engineering from Arizona State University, and a bachelor of science degree in chemical engineering from Cornell University. He sits on the board of directors of Creagh Medical in Galway, Ireland, a developer and manufacturer of specialty angioplasty balloons, and Pulsar Vascular in Santa Clara, Calif., an early stage developer and manufacturer of neurovascular implants for the treatment of hemorrhagic stroke. He also serves on advisory boards for Cornell's School of Biomedical Engineering and Chapman University's Schmid School of Science and Technology.
UC San Diego Health System
Chief of Staff